Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Goodwill & Intangibles (2018 - 2025)

Autolus Therapeutics (AUTL) has disclosed Goodwill & Intangibles for 6 consecutive years, with $20.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Goodwill & Intangibles changed N/A year-over-year to $20.3 million, compared with a TTM value of $20.3 million through Sep 2025, changed N/A, and an annual FY2024 reading of $12.4 million, changed N/A over the prior year.
  • Goodwill & Intangibles was $20.3 million for Q3 2025 at Autolus Therapeutics, up from $12.9 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $20.3 million in Q3 2025 and bottomed at $25000.0 in Q2 2022.
  • Average Goodwill & Intangibles over 4 years is $9.7 million, with a median of $12.4 million recorded in 2024.